Approach
Technology
Pipeline
About
About Octant
Blog
News
Careers
Octant Careers
Apprenticeship
Job Openings
Contact
Octant in the News
Octant Announces Collaborative AI Initiative with ARPA-H Funding to Advance Drug Discovery and Prevent Side Effects
October 23, 2024
Octant
Octant to Participate in the Canaccord Genuity Genetic Medicine for Generalists Webcast Series
October 1, 2024
Octant
Octant to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference
August 30, 2024
Octant
Octant to Present at the Goldman Sachs 45th Annual Global Healthcare Conference
June 11, 2024
Octant
Octant and BMS present "Deep Mutational Scan of TYK2 Reveals Protein-Drug Interactions” at Stanford Drug Discovery Symposium 2024
April 30, 2024
See Octant poster presentation on Deep Mutational Scan of TYK2
Octant
Octant announces the appointment of Chris Sinz, Matthew Albert, Rebecca Velez Frey, and Wen-Chen Yeh to key leadership positions
December 12, 2023
Octant wins "Technology and Tools" Award at Mutational Scanning Symposium 2022
June 13, 2022
See Octant poster presentation on Deep Mutational Scanning
Octant
Octant: leveraging cell barcoding for small molecule design
April 22, 2022
BioCentury
Octant sets sail for new era of drug discovery with $80M funding, Bristol Myers partnership
April 21, 2022
Fierce Biotech
Synthetic biology biotech nets three-hit combo in new financing, Bristol Myers deal and first CSO
April 21, 2022
Endpoints News
Octant Scores $80M in Series B Funds, Partnership with BMS
April 21, 2022
BioSpace
Octant Bio accepts $80m
April 21, 2022
Global Corporate Venturing
BMS joins Octant’s $80M financing and signs on as a drug discovery partner
April 21, 2022
MedCity News
SwabSeq: Scalable, Sensitive and Fast COVID-19 Testing
January 18, 2022
UCLA Newsroom
Octant continues pursuit of drug discovery
January 5, 2022
California NanoSystems Institute
How Open Source Bio-tech Scored a Deal for an East Bay Startup
December 10, 2020
San Francisco Business Times
Ginkgo Bioworks, Octant to Establish Bay Area Coronavirus Test Processing Facility
December 10, 2020
GenomeWeb
New UCLA coronavirus test has about 95% reliability rate: Octant CEO
October 9, 2020
Fox Business
Pharma’s Dirty Secret, And The Synthetic Biology Startup Offering A New Approach
June 29, 2020
Forbes
Emerging from stealth, Octant is bringing the tools of synthetic biology to large scale drug discovery
May 20, 2020
TechCrunch
With $30M, Octant Launches Synthetic Bio Search for Multi-Target Drugs
May 20, 2020
Xconomy
Andreessen Horowitz backs a new molecule builder from UCLA equipped with the latest in convergence tech. And he’s aiming big
May 20, 2020
Endpoints News
Navigating new world of synthetic biology, East Bay startup lands $30M, maps future of drug discovery
May 20, 2020
San Francisco Business Times
Octant emerges with $30M to untangle, exploit pathways hit by dirty drugs
May 20, 2020
BioCentury